The Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

116 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-16

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to evaluate the Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal Stenosis

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Limaprost in Combination With Transforaminal Epidural Steroid Injection

NCT04876612

Lumbar Spinal Stenosis

RECRUITING NA

Efficiency of Surgical Treatment for Lumbar Spinal Stenosis

NCT03365401

Lumbar Spinal Stenosis

UNKNOWN NA

Study to Evaluate Safety and Effectiveness of Dynamic Stabilization Versus Lumbar Fusion in Treatment of Multilevel Lumbar Disc Degeneration Disease

NCT02385695

Lumbar Spine Disc Degeneration

UNKNOWN

Effects and Safety of Epidural PDRN vs. Placebo

NCT04401735

Spinal Stenosis Lumbar

UNKNOWN PHASE4

Change of Lumbar Symptom After Surgical Treatment for Patients With Cervical Stenosis

NCT03089931

Cervical Myelopathy Spondylosis Low Back Pain

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Spinal Stenosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dong-A Opalmon® Tab

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women aged ≥ 19 years
* Subjects with acquired Lumbar Spinal Stenosis who show normal results in the Straight Leg Raising (SLR) test and exhibit intermittent claudication, requiring treatment with Dong-A Opalmon® tab
* Subjects who voluntarily consent to participate in this observational study

Exclusion Criteria

* Subject for whom the medicinal products administration is contraindicated according to the approved domestic drug information: Pregnant women or those who may be pregnant, Subject with genetic disorders such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption
* Subjects considered as unsuitable for participation in this observational study by the principal investigator or sub-investigator

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No